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Abstract 
 
Johnsson, P. 2004. Phenolic compounds in flaxseed: Chromatographic and 
spectroscopic analyses of glucosidic conjugates.  
Licentiate thesis. ISSN 1101-5411, ISBN 91-576-6630-x 
 
The dietary lignan secoisolariciresinol diglucoside (SDG), present in high 
concentrations in flaxseed, and its metabolites enterolactone and enterodiol are 
thought to decrease the risk of hormone dependent cancers, cardiovascular disease 
and other “welfare” diseases. Flaxseed also contains other biologically active 
phenolic compounds, such as phenolic acids. The understanding of the nature of 
these compounds is crucial for their possible exploitation in drugs and functional 
foods. Until the mid 1990’s, the number of methods available for analysis of 
lignans and other compounds in flaxseed was limited and were divergent in terms 
of yields. Moreover, the structure of a “flaxseed polymer” to which these phenolic 
compounds are bound was not known. Thus, the aim of the work presented in this 
thesis was to develop a quantitative method for analysis of SDG in flaxseed and to 
unravel the structure of the “polymer”. 
 
A high performance liquid chromatography (HPLC) method for quantification 
of SDG in a base hydrolysed dioxane/ethanol flaxseed extract was developed. The 
method was applied to study the SDG content in 14 Swedish and 15 Danish 
flaxseed cultivars. The SDG content in defatted flour from the cultivars varied 
between 11.7 and 24.1 mg/g (6.1 – 13.3 mg/g in dried seeds).  
 
Two chromatographic peaks eluting before SDG in the developed HPLC system 
were identified as 4-O-β-D-glucopyranosyl-p-coumaric acid and 4-O-β-D-
glucopyranosyl-ferulic acid by liquid chromatography-mass spectrometry and 
nuclear magnetic resonance (NMR) analyses. Moreover, by the use of different 
NMR techniques, a strait chain oligomeric structure with an average composition 
of five SDG residues interlinked with four 3-hydroxy-3-methyl glutaric acid 
residues was assigned to the “polymer”. 
 
Keywords:  Linum usitatissimum, lignans, phenolic acids, polymer, oligomer, 
complex, glucosides, HPLC, NMR. 
 
Author’s address: Pernilla Johnsson, Department of Food Science, P.O. Box 7051, 
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Sammanfattning 
 
Linfrö innehåller höga halter av lignanen secoisolariciresinol diglukosid (SDG) 
som som sådan, eller omvandlad till de metaboliska produkterna enterolakton och 
enterodiol, tros kunna hämma vissa hormonberoende cancersjukdomar, 
hjärtkärlsjukdomar och andra “välfärdssjukdomar”. Linfrö innehåller också andra 
biologiskt aktiva fenolföreningar, som t. ex. fenoliska syror. Kännedom om dessa 
ämnens egenskaper är nödvändig för deras eventuella användning  i sk. 
mervärdesmat eller mediciner. Vid mitten av 1990-talet så var antalet metoder för 
analys av lignaner och andra föreningar i linfrö fortfarande begränsat, och de gav 
starkt varierande resultat i fråga om halter. Dessutom kände man inte till 
strukturen på det “linfröpolymer” i vilket dessa ämnen är bundna. Arbetet som 
presenteras i denna avhandling syftade därför till att utveckla en kvantitativ metod 
för SDG i linfrö och att utreda “polymer”-strukturen. 
 
En HPLC-metod (high performance liquid chromatography) för kvantitativ 
bestämning av SDG i dioxan/etanol-extraherade bashydrolysat av linfrö 
utvecklades. Metoden användes sedan för att analysera SDG-innehållet i 14 
svenska och 15 danska linfrösorter. SDG-innehållet i avfettat linfrömjöl från de 
olika sorterna varierade mellan 11.7 and 24.1 mg/g  (6.1 – 13.3 mg/g i torkade 
hela frön).  
 
Två kromatografiska toppar som elueras före SDG i den framtagna HPLC-
metoden identifierades som 4-O-β-D-glukopyranosyl-p-coumarsyra och 4-O-β-D-
glukopyranosyl-ferulasyra med hjälp av LC-MS (liquid chromatography-mass 
spectrometry) och NMR (nuclear magnetic resonance). Med hjälp av olika NMR-
tekniker tillskrevs “polymeren” en oligomerisk strukur bestående av en rak kedja 
med ett genomsnittligt innehåll av fem SDG molekyler sammanbundna av fyra 
molekyler av 3-hydroxy-3-metylglutarsyra.  
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Background 
 
The incidence and mortality of cancers of the breast, prostate and colon are higher 
in the western world compared to Asian countries (World Cancer Research Fund, 
1997). In some western countries, e.g. Finland, there is a regional difference in 
cancer incidence possibly caused by differences in diet and lifestyle (Adlercreutz, 
1990). Moreover, population and immigrant studies have shown that the incidence 
of the mentioned cancers has increased for Japanese who have immigrated to USA 
and changed their dietary habits (Dunn, 1975; Tominaga, 1985). There is now 
convincing evidence that a diet rich in whole grain, fruits and vegetables decreases 
the risk of developing coronary artery diseases, diabetes and cancer (Adlercreutz, 
1990; Kushi et al., 1999; Adlercreutz, 2002; Bhathena and Velasquez, 2002; Kris-
Etherton et al., 2002). Thus, the Swedish National Food Administration, along 
with other international authorities, recommends an increased consumption of 
these food products (National Food Administration, 2004). 
 
The “western world” diet, typically high in fat and protein and low in fibre and 
whole-grain products, is associated with high levels of endogenous sex hormones 
and low levels of sex hormone binding globulin (SHBG) (Adlercreutz, 1990). 
These factors may play an important role in the development of hormone 
dependent cancers such as breast, prostate and endometrial cancer. Also, coronary 
heart disease and colon cancer may result from such a dietary pattern due to 
unfavourable plasma lipid levels and intestinal bile acid metabolism. 
 
In the 1970’s, a class of compounds called lignans, especially abundant in fibre 
rich parts of plants, was recognised by the National Cancer Institute (USA) as 
high-interest compounds with regard to antitumour activity (Hartwell, 1976; 
Barclay, 1976). A few years later, the “mammalian lignans” enterolactone and 
enterodiol, were discovered in human urine (Setchell et al., 1980 b; Stich et al., 
1980; Setchell et al, 1981). Their excretion in urine from human females was 
shown to vary during the reproductive cycle, which suggested a physiological 
function related to hormone metabolism (Setchell et al., 1979; Stich et al., 1980). 
Eventually, this lead to the assumption that fibre-rich plant foods containing 
hormone like compounds such as lignans and isoflavonoids, also known as phyto-
oestrogens, may influence oestrogen metabolism and reduce the incidence of 
colon and breast cancer and possibly other diseases (Adlercreutz, 1984; Horwitz 
and Walker, 1984; Adlercreutz, 1990). 
 
Plant lignans are phenolic secondary metabolites whose basic structure is a 2,3-
dibenzylbutane (Figure 1). In plants, they are thought to act as growth regulators 
or as a defence towards external threats (Ayres and Loike, 1990). The number of 
identified lignans is steadily increasing. As they possess a wide variety of 
biological activities such as antitumour, antimitotic, inhibition of DNA and RNA 
synthesis, antiviral, inhibition of enzyme activity, anti-insect, antimicrobial and 
fungistatic (MacRae and Towers, 1984), they are gaining an ever-increasing 
interest in research. 
   12
 
Figure 1. The basic structure of lignans. 
 
Dietary lignans 
 
Flaxseed – a rich source of plant lignans 
The levels of lignans in food vary widely, the by far richest source being flaxseed 
(Linum usitatissimum L.) which contains tens to hundreds of times more than most 
other edible plants (Table 1).  
 
 
Table 1. Levels of lignans in different food plant products 
 
Plant source  Lignan   Level  (mg/kg; dry 
weight) 
Reference 
 
Flaxseed 
 
SECO
a 
Matairesinol 
Matairesinol 
 
 
SDG 
 
 
3699  
10.9  
7-28.5
b 
 
 
11900-25900
 c 
 
 
Mazur et al., 1996 
  - “ - 
Kraushofer and 
Sontag, 2002 
 
Eliasson et al., 2003 
 
Sesame seed  Sesamin 
Sesamolin 
1547-8852
d 
1235-4765
d  
 
Namiki, 1995 
Cereals SECO 
Matairesinol 
0.1-1.3 
0-1.7 
 
Mazur and 
Adlercreutz, 1998 
Vegetables SECO 
Matairesinol 
0.1-38.7 
trace-0.2 
 
Mazur and 
Adlercreutz, 1998 
Legumes SECO 
matairesinol 
0-15.9  
0-2.6 
 
Mazur et al., 1998 a 
Fruits SECO 
matairesinol 
trace-30.4 
0-0.2 
 
Mazur, 1998; 
Mazur and 
Adlercreutz, 1998 
Berries SECO 
Matairesinol 
1.4-37.2 
0-0.8  
 
Mazur et al., 2000 
Tea SECO 
matairesinol 
15.9-81.9  
1.6- 11.5  
Mazur et al., 1998 b 
a Obtained by enzymatic or acid hydrolysis; 
b Not reported whether it is of fresh weight 
or dry weight; 
c Obtained by alkaline hydrolysis;
d  In oil.   13 
The prevailing lignan in flaxseed is secoisolariciresinol diglucoside (SDG; Bakke 
and Klosterman, 1956; Bambagiotti-Alberti et al. 1994a) which is often referred to 
as secoisolariciresinol or SECO, the aglycone of SDG, (Mazur et al., 1996) 
depending on the method of analysis (Figure 2). SDG exists in two isomeric forms 
in flaxseed (Bambagiotti-Alberti et al. 1994 b). Smaller quantities of matairesinol, 
isolariciresinol, lariciresinol, demethoxy-secoisolariciresinol and pinoresinol have 
also been identified in flaxseed (Figure 2) (Meagher et al., 1999; Sicilia et al., 
2003). 
 
 
 
Figure 2. Lignans that have been identified in flaxseed (demethoxy-SECO is missing one of 
the methyl groups). 
 
Other food sources of lignans are e.g., seeds, legumes, cereals, vegetables, berries, 
seaweed, tea and alcoholic beverages (Thompson et al., 1991; Namiki, 1995; 
Mazur et al., 1996; Mazur, 1998; Mazur et al., 1998a, b, c; Liggins et al., 2000; 
Mazur et al., 2000; Nurmi et al., 2003). Quantitative data on some lignans in food 
are presented in Table 1. 
 
The lignan content in flaxseed differ between varieties but is also dependent on 
growing location and year (Thompson et al., 1997; Westcott and Muir, 1996 b). 
There are few studies on the stability of lignans through food processing. Two 
studies performed by the same authors showed that SDG levels remained 
unchanged during the manufacture of breads and cookies that contained flaxseed 
(Westcott and Muir, 1996 b; Muir and Westcott, 2000). 
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Metabolism 
In the early 1980’s, the “mammalian” lignans enterodiol and enterolactone (Figure 
3) were identified as lignans of animal origin differing from plant lignans in 
carrying phenolic hydroxyl groups only in the meta position of the aromatic rings. 
They were found in urine, plasma and bile as glucuronide and sulphate conjugates, 
and in unconjugated forms in faeces. It was shown that the compounds undergo 
enterohepatic circulation where conjugates are formed in the liver, excreted in the 
bile, deconjugated by intestinal bacteria and then reabsorbed from the gut (Setchell 
et al., 1979; Axelson and Setchell, 1980; Setchell et al., 1980; Axelson and 
Setchell, 1981; Setchell et al., 1981). Later, SDG, matairesinol (Axelson et al. 
1982), lariciresinol, pinoresinol (Heinonen et al., 2001) and lignin in plant cell 
walls (Begum et al., 2004) have been identified as mammalian lignan precursors. 
Cereals, oilseeds, fruits and vegetables are rich sources of these precursors 
(Thompson et al., 1991). Enterodiol and enterolactone are formed by oxidation of 
precursors by facultative bacteria in the intestinal tract of animals and humans 
(Figure 3) (Axelson and Setchell, 1981; Setchell et al. 1981; Borrielo et al. 1985). 
 
 
 
Figure 3. Conversion of mammalian lignan precursors SDG and matairesinol to enterodiol 
and enterolactone by the gut microflora. 
 
Chemically unchanged lignans (matairesinol, lariciresinol, isolariciresinol, 
secoisolariciresinol) have been detected in low amounts in human urine. The cause 
may be precursor overload or insufficient bacterial capacity (Bannwart et al., 
1989; Rickard et al., 1996). 
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Physiological and health effects 
Enterolactone and enterodiol were found to be excreted in urine in changing 
amounts during the reproductive cycle of humans and vervet monkeys with a 
maximum during the luteal phase and early pregnancy. The excretion was 
negatively correlated to that of oestrogen (Setchell et al., 1979; Setchell et al., 
1980; Stich et al., 1980). The content of enterolactone and enterodiol in plasma 
and urine of pre- and postmenopausal women was shown to be significantly 
higher in vegetarian compared to omnivorous subjects. Breast cancer patients 
excreted lower amounts of mammalian lignans than did healthy omnivorous and 
vegetarian women in spite of a similar fibre intake to omnivorous women 
(Adlercreutz  et al., 1982). Since mammalian lignans and their precursors are 
similar to steroids in size and polarity, and are sterically similar to 17β-oestradiol 
(Figure 4) regarding the distance between the two –OH groups (Tham et al., 
1998), it was suggested that these lignans might play a physiological role linked 
with hormone metabolism (Setchell et al., 1981; Adlercreutz, 1984; Horwitz and 
Walker, 1984). 
 
 
 
Figure 4. 17β-oestradiol 
 
A reduced breast cancer risk has been reported for subjects with high urine and 
plasma levels of mammalian lignans (Dai et al., 2002; Ingram et al., 1997; 
Boccardo et al., 2004). However, this association could not be established for 
Dutch menopausal women in a study by Tonkelaar et al. (2001). Changes in 
hormone metabolism resulting in a reduced lifetime exposure to oestrogen (e.g. 
later onset of puberty) may be cancer protective (Tou and Thompson, 1999). 
Female rats had a delayed puberty onset with lifetime exposure to a 5 % flaxseed 
diet, whereas a lifetime exposure to a 10 % diet led to earlier puberty onset, higher 
serum oestradiol levels and a longer oestrous cycle. In this case, the 5 % diet may 
be protective whereas the 10 % diet might stimulate cancer development. SDG in 
an amount that corresponds to 5 % flaxseed gave the same result, indicating that it 
is the compound that is responsible for the effect (Tou et al., 1998). Other effects 
with significance to mammary cancer have been noticed. Pure SDG (1.5 mg/ day 
for 20 days), when administered to rats at the early promotion stage of mammary 
tumourigenesis, was shown to reduce the number of tumours. At the same time, 
urinary excretion of mammalian lignans was also shown to increase significantly 
(Thompson et al., 1996 b). The total volume of established and new mammary 
tumours was significantly decreased in rats that were fed SDG or flax. The size of 
O H
OH CH3  16
established tumours was inversely related to urinary excretion of mammalian 
lignans (Thompson et al., 1996 a). According to a review by Adlercreutz (2002), a 
plasma enterolactone concentration of 30-70 nmol/l is likely to protect against 
breast cancer. Plasma levels of enterolactone were 8.3-38.2 nmol/l in 
premenopausal women who ingested 25 g flaxseed/day for eight days (Nesbitt et 
al., 1999) and has been shown to increase by 37 % for each 10 g increase in fibre 
intake (Horner et al., 2002). 
 
Dietary lignans may also protect against prostate and colon cancer (Adlercreutz, 
2002). High levels of enterolactone in prostatic fluid may indicate a lower risk of 
prostate cancer (Morton et al., 1997). A 5 % flaxseed diet inhibited growth and 
development of prostatic carcinoma in mice (Lin et al., 2002) possibly due to 
hormonal effects of the flaxseed lignans. In male rats, a 5 % lifetime diet reduced 
the prostate cell proliferation rate and prostate weight without a raise in sex 
hormone levels. A 10 % lifetime diet on the other hand resulted in higher serum 
testosterone and oestradiol levels and prostate cell proliferation. Again, the 5 % 
diet seemed to be protective whereas the 10 % diet might be at risk of stimulating 
cancer development. Results indicated that SDG is responsible for the effect (Tou 
et al., 1998). Diets supplemented with flaxseed, flaxmeal (2.5 or 5 %) or SDG 
(daily gavage of 1.5 mg) showed a protective effect against colon cancer in rats 
(Jenab and Thompson, 1996). 
 
The reason for the cancer inhibiting activity of mammalian lignans and their 
precursor may be that they possess oestrogenic/anti-oestrogenic effects. A 
decreased formation and circulation of endogenous oestrogens limit stimulation of 
oestrogen dependent tumours. A compound with weak oestrogenic effect can be 
anti-oestrogenic when competing with a compound that has a stronger oestrogenic 
effect. The effect is dependent on the dose, timing and duration of exposure (Tou 
et al., 1998). In a study by Mousavi and Adlercreutz (1992), oestradiol and 
enterolactone, per se, stimulated the growth of MCF-7 breast cancer cells in vitro, 
but together they inhibited each others effect. Enterolactone was found to inhibit 
the binding of oestradiol and testosterone to SHBG in vitro in a dose-dependent 
manner with effective concentration range of 5-50 µM (Martin, et al., 1996). 
Aromatase (oestrogen synthetase) is an enzyme which is involved in oestrogen 
formation. Adlercreutz et al. (1993) showed that enterolactone caused a 50 % 
inhibition of aromatase at a concentration of 14 µM. Also, demethylated forms of 
matairesinol and enterolactone as well as demethylated secoisolariciresinol and 
enterodiol respectively, were shown to be moderate to weak inhibitors of 
aromatase activity in human preadipocytes (Wang et al., 1994). Moreover, 
enterolactone has been shown to depress oestrogen-stimulated RNA synthesis in 
rats (Waters and Knowler, 1982). 
 
Flaxseed low in α-linolenic acid (<3%), was shown to decrease the level of 
atherosclerotic plaques in rabbits (Prasad et al, 1998). High serum enterolactone 
concentrations were correlated with a decreased level of in vivo lipid peroxidation 
(Vanharanta et al., 2002), and were also protective against acute coronary heart 
events in men as suggested by a case-control study (Vanharanta et al., 1999). 
Cardio protective effects may be due to inhibition of lipid peroxidation or changes 
in SHBG production, and circulation of cholesterol (Vanharanta et al., 1999;   17 
Vanharanta et al., 2002). A low rate of lipid peroxidation may lower the risk of 
atherogenesis (Chisolm and Steinberg, 2000). Decreases in lipid peroxidation is 
perhaps not caused by enterolactone but by its precursors matairesinol, and SECO 
or SDG (Prasad, 1997;  Prasad, 1999). Primarily SDG, SECO, and matairesinol 
but also enterolactone and enterodiol have been shown to possess antioxidant 
activity in vitro (Kitts et al., 1999; Prasad, 2000; Niemeyer and Metzler, 2003). 
Moreover, SDG was demonstrated to prevent the development of type I and II 
diabetes in diabetes prone rats probably by decreasing oxidative stress in body 
tissues (Prasad, 2000; Prasad, 2001). There are, however, results that may have a 
negative influence on the development of cardiovascular disease. SDG and its 
oligomer, when fed to rats, were shown to significantly increase the amount of 
cholesterol in the liver and liver lipids (p<0.05), and to decrease rat plasma content 
of α- and γ–tocopherols (p<0.001) (Frank et al., 2004). Also flaxseed was found 
to cause a significant reduction in α- and γ–tocopherol levels in rats (Ratnayake, et 
al., 1992). Reduced levels of vitamin E, γ-tocopherol in particular, have been 
associated with an increased risk for cardiovascular disease (Hensley et al., 2004). 
 
In spite of all the evidence pointing towards health protective effects of 
enterolactone and enterodiol, the results are sometimes confusing and 
contradictive. The determinants or causes of their excretion may be a more 
important factor than the single compounds. Also, a low fat intake and a healthy 
and viable gut microflora may be crucial for a decreased risk of many diet-related 
diseases. Whether mammalian lignans really are effective or if they are merely 
indicators of a healthy diet has yet to be established (Adlercreutz, 2002; 
Adlercreutz, 2003). 
 
 
Other phenols in flaxseed 
 
Apart from lignans, flaxseed has been reported to contain free phenolic acids, 
glycosylated phenolic acids and flavonoids. Due to varying methodologies, reports 
on quantities and types (e.g. free, ester bound etc.) of phenolic acids in flaxseed 
are diverging and confusing. Kozlowska et al. (1983), showed that the highest 
proportion of phenolic acids in flaxseed and other oil seeds were ester bound. By 
extraction with 80 % methanol, the content of ester bound phenolic acids in 
flaxseed was 320 mg/kg defatted flaxseed flour (DFF), the main constituents being 
p-hydroxybenzoic, trans-ferulic and trans-p-coumaric acids. Free phenolic acids, 
present at 200-280 mg/kg defatted flaxseed flour, were mainly composed of trans- 
and  cis-sinapic,  o-coumaric,  p-hydroxybenzoic,  trans-p-coumaric and vanillic 
acids. The content of residual (non-extractable with the method used) phenolic 
acids was 70 mg/kg DFF. Dabrowski and Sosulski (1984), found no free phenolic 
acids when extracting DFF with tetrahydrofuran. Alkaline hydrolysis released 730 
mg phenolic acids/kg DFF (89 % of total phenolic acids), the major ones being 
trans-ferulic and trans-sinapic acid. Harris and Haggerty (1993) reported a content 
of ca 11 mg ferulic acid/kg in whole flaxseed. They did not use alkaline hydrolysis 
and, thus, they could not detect ester bound phenolic acids. Oomah et al. (1995) 
reported a content of 8000-10 000 mg total phenolic acids/kg flaxseed of which   18
48-66% was assigned to esterified phenolic acids. Phenolic acids that were not 
released after extraction and alkaline hydrolysis were assumed to be ether bound. 
Variations in phenolic acid content in flaxseed were largely attributed to seasonal 
effects (Oomah et al., 1995). 
 
Glycosides of p-coumaric, ferulic, and caffeic acid have been detected in 
flaxseed (Westcott and Muir, 1996 a; Westcott and Muir, 2000; Eliasson et al., 
2003). Linocinnamarin (4-[β-D-glucopyranosido]-hydroxycinnamate) was first 
isolated from flaxseed by Klosterman et al. (1954). The compound linusitamarin 
(methyl 3-β-D-glucopyranosyl-5-methoxycinnamate) was assigned by Luyengi et 
al. (1993). However, the structure of this compound was probably misinterpreted 
as far as the 3/5 substitution is concerned which is a very uncommon substitution 
pattern (Westcott and Muir, 2000). It was more likely to be a ferulic acid 
glucoside (methyl 3-β-D-glucopyranosyl-4-methoxycinnamate) as supported by 
NMR analyses performed by Westcott and Muir (2000). Flavonoids are also 
present in flaxseed in high amounts with reported means of 490-870 mg/kg DFF. 
The content was influenced by both cultivar and environment (Oomah et al., 
1996). 
 
The above mentioned plant phenols may function as blocking or trapping agents 
for chemically induced cancers caused by aromatic carcinogens. A continuous 
input of these protecting compounds may serve as a buffer against cell damage by 
quantitative and qualitative supplementation of endogenous protective systems. 
The conjugated groups, e.g. sugar moieties, function as protection of the easily 
oxidised and biologically more potent free forms which are released upon acid or 
enzymatic hydrolysis in the gastro-intestinal tract of animals and humans 
(Newmark, 1984). 
 
 
Analysis of phenolic compounds in flaxseed 
 
Following the discovery of SDG by Bakke and Klosterman (1956) and its 
connection to the mammalian lignans, several methods for the analysis of lignans 
and other constituents of the fat free portion of flaxseed have been developed, 
although only a few quantitative. In order to obtain repeatable results, defatting of 
flaxseed cake prior to further treatment has been deemed crucial (Kozlowska et 
al., 1983; Harris and Haggerty, 1993). The polymeric powder obtained by 
ethanol:dioxane extraction of DFF was found to release hydroxy methyl glutaric 
acid (HMGA; Figure 5), 4-O-β-D-glucopyranosyl coumaric acid, and SDG upon 
base hydrolysis (Klosterman and Smith, 1954; Klosterman et al.,  1955; Bakke 
and Klosterman, 1956), suggesting that these compounds are bound in an ester 
linked polymeric structure(s) in flaxseed. The compounds may also be released 
from the polymeric material as aglycones by enzyme or acid hydrolysis (Setchell 
et al., 1981; Mazur et al., 1996). 
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Figure 5. Hydroxy methyl glutaric acid. 
 
Extractions of flaxseed phenols have usually been carried out with organic 
solvents (Bakke & Klosterman, 1956; Bambagiotti-Alberti et al., 1994 a; Rickard 
et al., 1996; Chimichi et al., 1999) sometimes mixed with water (Axelson et al., 
1982; Kozlowska et al., 1983; Dabrowski and Sosulski, 1984; Amarowicz et al., 
1994; Westcott and Muir, 1996; Meagher et al., 1999; Ford et al., 2001; Charlet et 
al., 2002; Degenhardt et al., 2002; Sicilia et al., 2003), but  the use of supercritical 
fluid (SCF) extraction has also been reported (Harris and Haggerty, 1993). SDG 
and the cinnamic acids absorb light in the UV-region and have been detected and 
quantified by column chromatography, HPLC, GC and NMR techniques. 
 
The differences in efficiency of different modes of extractions and hydrolyses 
have resulted in a broad variation in yields. In Table 2, methods for quantification 
of SDG in flaxseed have been compiled. 
CH2
COOH
CH3
CH2
OH
COOH  20  21 
Objectives 
 
The aims of the studies include in this thesis were: 
 
To develop an HPLC method for the quantification of SDG in flaxseed (Paper I). 
 
To identify two major peaks that elute before SDG in the HPLC-system developed 
in Paper I, and to obtain preliminary information on the “flaxseed polymer” by 
chromatographic and spectroscopic analyses (Paper II). 
 
To elucidate the structure of the “flaxseed polymer” by chromatographic and 
spectroscopic analyses (Paper III). 
   22
Analytical procedures 
 
An outline of the work resulting in papers I-III is shown in Figure 6. (For more 
detailed descriptions, see Paper I-III).  
 
In Paper I, SDG was purified from a flaxseed extract by reversed and normal 
phase column chromatography for use as an external standard in quantifications 
and for future reference. The identity and purity of the isolated SDG was 
determined by proton nuclear magnetic resonance (
1H NMR). A high performance 
liquid chromatography (HPLC) method for the quantitative determination of SDG 
in flaxseed was developed and used for analysis of SDG in Swedish (n = 14) and 
Danish (n = 15) flaxseed cultivars. SDG was detected by UV- diode array 
detection (DAD) and its content in flaxseed was calculated using a six point linear 
standard curve (R
2 =  0.999). 
 
In Paper II, a flaxseed extract, “whole polymer”, was fractionated with 0-100 % 
methanol (in 10 %-unit intervals) on a C18 reversed phase solid phase extraction 
(SPE) column yielding 11 fractions. The fractions were analysed by HPLC. The 
“whole polymer” and its main UV-absorbing fractions, eluted with 50, 60 and 70 
% aqueous methanol, were analysed by one- and two-dimensional NMR 
techniques (
1H NMR, COSY, HSQC-DEPT and HMBC) in order to get structural 
information on the polymer. The same polymeric fractions were also subjected to 
alkaline hydrolysis and analysed by HPLC. SDG was identified by comparison 
with a standard (see above) and two other major peaks in the chromatograms were 
investigated by LC-MS and NMR. The compounds representing the two HPLC-
peaks were isolated from an aqueous SPE fraction by normal phase column 
chromatography and identified by NMR. The sugar content and the yield of the 
“whole polymer” were determined by qualitative sugar analysis (Theander et al., 
1995) and gravimetrical determination respectively. 
 
To obtain the major fraction of the polymer for the experiments in Paper III, 
the “whole polymer” was washed on a SPE column with 50% aqueous methanol 
and then eluted with 60 % methanol. To elucidate the structure of the SDG-
complex, the fraction was analysed by different NMR techniques (
1H NMR, 
13C 
NMR, TOCSY, HSQC-DEPT and HMBC). Standard SDG (see above) and 
HMGA (Sigma-Aldricht Chemie, Germany) were used as reference compounds.   23 
 
Figure 6. Overview of analytical procedures and outcomes of Paper I-III.  
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Results and discussion 
 
In 1998, at the beginning of this work, the nature of the extractable phenolic 
polymer first described by Klosterman and Smith (1954) was not known. 
Moreover, reports on the SDG/SECO content in flaxseed showed a great variation 
(Table 2), and values were often surprisingly low considering the high amounts of 
mammalian lignans that were excreted in urine of humans and animals (Axelson et 
al., 1982; Thompson et al., 1991) after flaxseed ingestion. Our aim was thus to 
develop a quantitative method for the analysis of SDG in flaxseed and to learn 
more about the complex in which SDG is included. This work is presented in three 
published papers (see Figure 6 and Appendix), and summarised hereafter. 
 
In Paper I, defatted flaxseed flour (DFF) was extracted with 1,4-dioxane/95 % 
ethanol (1:1, v/v) and hydrolysed in methanolic base according to Bakke and 
Klosterman (1956). Upon repeated HPLC analyses it was discovered that the first 
two peaks in the chromatogram (later assigned to p-coumaric and ferulic acid 
glucosides, see below) were diminished and some extra peaks eluted later, close to 
the SDG peak. When hydrolysis was carried out with aqueous base instead, the 
two peaks remained stable, suggesting formation of less polar derivatives due to 
transmethylation of carboxylic groups in the methanolic system. The yield of SDG 
was unaffected regardless of the method of hydrolysis but the separation of HPLC 
peaks around the SDG peak was much better when hydrolysis was performed in 
water. Thus, aqueous base hydrolysis was chosen for further work. Figure 7 
presents a typical HPLC chromatogram of the base-hydrolysed extract from 
flaxseed. The HPLC gradient developed in this study provided a very good 
separation for SDG, easier interpretation of its UV-DAD and LC-MS spectra and 
required less time compared to others (Westcott and Muir, 1996 b). 
 
 
 
Figure 7. A typical chromatogram of a base hydrolysed dioxane/ethanol extract from 
flaxseed. 
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The method developed above was used to study the variation in SDG content in 
flaxseed cultivars grown in Sweden (n = 14) and Denmark (n = 15). 
Concentrations were calculated with the help of a standard curve produced using 
purified SDG at the concentrations 0, 20, 40, 80, 120 and 160 µg/ml (y = 3.69x – 
9.21; R
2 = 0.999). The level of SDG in these 29 samples varied between 11.7 and 
24.1 mg/g in DFF and between 6.1 and 13.3 mg/g in whole seeds. The levels are 
in agreement with those obtained by Rickard et al. (1996), Westcott and Muir 
(1996 a), Liggins et al. (2000) and Charlet et al. (2002) (Table 2). Eliasson et al. 
(2003) reported a slightly higher yield for SDG with direct alkaline hydrolysis 
compared to the method in this study. When 27 different cultivars were analysed, 
the mean SDG yield was approximately two-fold compared to that found in this 
study (Table 2). The difference may be due to the efficiency of the analytical 
procedure, but may also be due to differences between years, cultivars or growing 
locations. Westcott and Muir (1996 b) found a double-fold variation in flaxseed 
lignan concentration and noted that the variation was mainly due to cultivation 
year, with secondary importance to variety, and less importance to cultivation 
location. 
 
In  Paper II, LC-MS of the first two peaks in the chromatograms of the 
hydrolysed polymers (eluting at 12.8 and 14.6 min; Figure 7) showed ions 
corresponding to 4-O-β-D-glucopyranosyl-p-coumaric acid and 4-O-β-D-
glucopyranosyl-ferulic acid (Figure 8). Their structures were determined by NMR 
and found to be in accordance with NMR data presented by Luyengi et al. (1993) 
and Westcott et al. (2000) for 4-O-β-D-glucopyranosyl-p-coumaric acid and 4-ο-
β-D-glucopyranosyl-ferulic acid respectively. 
 
 
 
Figure 8. Coumaric acid glucoside (R = H); ferulic acid glucoside (R = OMe). 
 
Paper II also sought an insight into the structure of the “flaxseed polymer”. The 
yield of the extract from DFF was 2.9 % as determined gravimetrically. Others 
have reported yields of 2-4 % (Klosterman and Smith, 1954; Bakke and 
Klosterman, 1956) and 10-11.5 % (Bambagiotti-Alberti et al., 1994 a) in DFF, and 
4.9 % in whole seed (Degenhardt et al., 2002). Sugar analysis showed that the 
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only sugar residue present in the extract was glucose. Three fractions of the whole 
extract were obtained by eluting an SPE-column with 50, 60 and 70 % aqueous 
methanol. Figure 9 shows HPLC chromatograms of the whole extract and the 
three fractions.  
 
 
 
Figure 9. Chromatogram of an unhydrolysed flaxseed extract (“whole extract”) and three 
fractions obtained by eluting an SPE column with 50, 60 and 70 % aqueous methanol. 
 
The broad peaks are transformed to sharp peaks upon hydrolysis (Figure 7). 
Thus, the broad nature of the unhydrolysed peaks suggested a variation in e.g. 
molecular weight, substituent and/or substitution pattern. On basis of the peak 
area, the 60 % fraction was the largest fraction (ca 64 %), followed by the 50 % 
fraction (ca 23 %) and the 70 % fraction (ca 13 %). The “whole polymer” and its 
three fractions were similar with regard to the nature of their components 
absorbing in the UV range used for detection (210-400 nm). However, the relative 
ratios of the components of the three polymeric fractions differed. The HPLC 
chromatogram of the hydrolysed 60 % fraction, the major part of the polymer, was 
most similar to that of the the “whole polymer”. The 70 % fraction was rather 
similar to the 60 % fraction but had a slightly higher proportion of SDG compared 
to other components. The 50 % fraction, on the other hand, was clearly different in 
containing a much smaller proportion of SDG and a much higher proportion of the 
p-coumaric and ferulic acid glucosides. The same structural variations could be 
observed by 
1H NMR analysis.  
 
Paper III further investigated the structure of the “polymer” by additional 
NMR-analyses. 
1H NMR analysis revealed signals corresponding to the CH3 and 
CH2 groups of hydroxy methyl glutaric acid (HMGA). 
13C NMR showed peaks for 
SDG and HMGA residues but no visible peaks for the other phenols (mainly p-
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coumaric acid-O-glucoside and ferulic acid-O-glucoside). The carboxylic carbon 
signal assigned to HMGA was 2 ppm upfield as compared with that of the free 
HMGA indicating that HMGA is esterified in symmetrical structures. HSQC-
DEPT revealed two types of strong cross peaks showing that the C-6 of glucose in 
SDG was present in both non-esterified and ester-linked forms (Farah et al., 
1992). Since some of the C-6 of the glucose residues in SDG were ester-linked 
and some were not, some glucose residues must be in terminal position in the 
polymer. This finding was confirmed by TOCSY which showed two types of spin 
systems for the protons at positions 7, 8 and 9 where signals from the linked SDG 
were down-field compared to those from terminal SDG. HMBC revealed that the 
ester link is between the carboxylic carbon of HMGA and some of the C-6 of 
glucose. Taken together, these results suggested a linear and symmetrical structure 
composed of SDG and HMGA units. 
 
The structure of the “polymer” was elucidated from two types of calculations: 1) 
the ratio of terminal versus linked glucose residues in the polymer, and 2) the ratio 
between SDG and HMGA units. The ratio of terminal versus intermediate SDG 
groups was roughly calculated as 1:4 from the 
13C NMR spectrum by integration 
of the peaks of terminal and linked glucose. Integration of peaks in the 
1H NMR 
spectrum, two protons at positions 8 and four protons at positions 7 of SDG and 
the –CH2- groups of HMGA, gave an SDG/HMGA ratio of 0.56/0.44.  The 
average numbers of SDG and HMGA molecules in this polymer were calculated 
as 4.67 and 3.67, respectively. Both calculations support an average structure of ca 
4000 Da, containing two terminal and eight linked glucose residues (Figure 10). 
These results are in line with those of Ford et al. (2001) which suggest a family of 
SDG-HMGA dimers, trimers, tetramers and so forth to be present in mature 
flaxseeds. 
 
 
 
 
 
Figure 10. The structure of the flaxseed oligomer (average size, n = 3). 
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Conclusions and future research 
 
This work has led to the development of a method of analysis for SDG in flaxseed. 
Full spectroscopic data have been provided for 4-O-β-D-glucopyranosyl-p-
coumaric acid and 4-O-β-D-glucopyranosyl-ferulic acid isolated from flaxseed 
extracts. Finally, the structures of SDG containing oligomers in flaxseed have 
been determined. Flaxseed is not a major food plant, and its use as food is limited 
by its laxative properties and content of cyanogenic glucosides. But, given its high 
levels of biologically active lignans, flaxseed may still be added to foods as a 
health promoting ingredient. It is also a good model plant for method development 
and for use (in whole, as a polymeric extract or as separate compounds) in in vitro 
and in vivo studies. The”polymer” may be of more value in relation to health 
compared to SDG because of its higher water solubility and ease of extraction. 
Moreover, other compounds in flaxseed, e.g. HMGA and hydroxycinnamic acids 
may also contribute to positive health effects. Thus, knowledge about the 
oligomeric structure and its components is of importance from a nutritional and 
biochemical point of view and is crucial for a complete understanding and possible 
exploitation. 
 
The cinnamic acid glucosides are probably also incorporated into ester linked 
polymeric structures. This is supported by the fact that they too are released upon 
base hydrolysis. The structures of the polymers/oligomers containing these 
phenols have yet to be determined. It is not known if all SDG or cinammic acids 
are released by alkaline hydrolysis or if any other linkages, e.g. ether, are 
involved. Lam et al. (1992) showed that p-coumaric acid is present in ester and 
ether bound form in lignin-polysaccharide fractions from cell walls of wheat and 
Phalaris aquatica. Ferulic acid was mainly present in ester bound forms or 
included in ester-ether bridges. Further work is needed to unfold the bound 
structure(s) of these compounds.   30
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